Robert Irzmański1, Joanna Kapusta2, Agnieszka Obrębska-Stefaniak1, Beata Urzędowicz1, Jan Kowalski3. 1. Department of Internal Medicine and Cardiac Rehabilitation, Medical University of Lodz, Poland. 2. Department of Internal Medicine and Cardiac Rehabilitation, Medical University of Lodz, Kościuszki 4, Lodz 90-419, Poland. 3. Department of Internal Medicine and Cardiac Rehabilitation, Medical University of Lodz, Poland University of Social Science, Lodz, Poland.
Abstract
BACKGROUND: The prognosis in patients after acute coronary syndromes (ACS) is significantly burdened by coexisting anaemia, leukocytosis and low glomerular filtration rate (GFR). Hyperglycaemia in the early stages of ACS is a strong predictor of death and heart failure in non-diabetic subjects. This study aimed to evaluate the effect of hyperglycaemia, anaemia, leukocytosis, thrombocytopaenia and decreased GFR on the risk of the failure of cardiac rehabilitation (phase II at the hospital) in post-ST-segment elevation myocardial infarction (STEMI) patients. METHODS: The study included 136 post-STEMI patients, 96 men and 40 women, aged 60.1 ± 11.8 years, admitted for cardiac rehabilitation (phase II) to the Department of Internal Medicine and Cardiac Rehabilitation, WAM University Hospital in Lodz, Poland. On admission fasting blood cell count was performed and serum glucose and creatinine level was determined (GFR assessment). The following results were considered abnormal: glucose ⩾ 100 mg/dl, GFR < 60 ml/min/1, 73 m², red blood cells (RBCs) < 4 × 106/μl, white blood cells (WBCs) > 10 × 103/μl; platelets (PLTs) < 150 × 10³/ml. In all patients an exercise test was performed twice, before and after the completion of the second stage of rehabilitation, to assess its effects. RESULTS: Based on logistic regression analysis and the results of an individual odds ratio (OR) of the tested parameters, their prognostic impact was determined on the risk of failure of cardiac rehabilitation. This risk has been defined on the basis of the patient's inability to tolerate workload increment >5 Watt in spite of the applied program of cardiac rehabilitation. As a result of building a logistic regression model, the most statistically significant risk factors were selected, on the basis of which cardiac rehabilitation failure index was determined. leukocytosis and reduced GFR determined most significantly the risk of failure of cardiac rehabilitation (respectively OR = 6.42 and OR = 3.29, p = 0.007). These parameters were subsequently utilized to construct a rehabilitation failure index. CONCLUSIONS: Peripheral blood cell count and GFR are important in assessing the prognosis of cardiac rehabilitation effects. leukocytosis and decreased GFR determine to the highest degree the risk of cardiac rehabilitation failure. Cardiac rehabilitation failure index may be useful in classifying patients into an appropriate model of rehabilitation. These findings support our earlier reports.
BACKGROUND: The prognosis in patients after acute coronary syndromes (ACS) is significantly burdened by coexisting anaemia, leukocytosis and low glomerular filtration rate (GFR). Hyperglycaemia in the early stages of ACS is a strong predictor of death and heart failure in non-diabetic subjects. This study aimed to evaluate the effect of hyperglycaemia, anaemia, leukocytosis, thrombocytopaenia and decreased GFR on the risk of the failure of cardiac rehabilitation (phase II at the hospital) in post-ST-segment elevation myocardial infarction (STEMI) patients. METHODS: The study included 136 post-STEMI patients, 96 men and 40 women, aged 60.1 ± 11.8 years, admitted for cardiac rehabilitation (phase II) to the Department of Internal Medicine and Cardiac Rehabilitation, WAM University Hospital in Lodz, Poland. On admission fasting blood cell count was performed and serum glucose and creatinine level was determined (GFR assessment). The following results were considered abnormal: glucose ⩾ 100 mg/dl, GFR < 60 ml/min/1, 73 m², red blood cells (RBCs) < 4 × 106/μl, white blood cells (WBCs) > 10 × 103/μl; platelets (PLTs) < 150 × 10³/ml. In all patients an exercise test was performed twice, before and after the completion of the second stage of rehabilitation, to assess its effects. RESULTS: Based on logistic regression analysis and the results of an individual odds ratio (OR) of the tested parameters, their prognostic impact was determined on the risk of failure of cardiac rehabilitation. This risk has been defined on the basis of the patient's inability to tolerate workload increment >5 Watt in spite of the applied program of cardiac rehabilitation. As a result of building a logistic regression model, the most statistically significant risk factors were selected, on the basis of which cardiac rehabilitation failure index was determined. leukocytosis and reduced GFR determined most significantly the risk of failure of cardiac rehabilitation (respectively OR = 6.42 and OR = 3.29, p = 0.007). These parameters were subsequently utilized to construct a rehabilitation failure index. CONCLUSIONS: Peripheral blood cell count and GFR are important in assessing the prognosis of cardiac rehabilitation effects. leukocytosis and decreased GFR determine to the highest degree the risk of cardiac rehabilitation failure. Cardiac rehabilitation failure index may be useful in classifying patients into an appropriate model of rehabilitation. These findings support our earlier reports.
Authors: Piotr Jankowski; Maciej Niewada; Andrzej Bochenek; Krystyna Bochenek-Klimczyk; Maciej Bogucki; Wojciech Drygas; Dariusz Dudek; Zbigniew Eysymontt; Stefan Grajek; Adam Kozierkiewicz; Artur Mamcarz; Maria Olszowska; Andrzej Pająk; Ryszard Piotrowicz; Piotr Podolec; Jadwiga Wolszakiewicz; Tomasz Zdrojewski; Dominika Zielińska; Grzegorz Opolski; Janina Stępińska Journal: Kardiol Pol Date: 2013 Impact factor: 3.108
Authors: Diaa A Hakim; George D Dangas; Adriano Caixeta; Eugenia Nikolsky; Alexandra J Lansky; Jeffrey W Moses; Bimmer Claessen; Elias Sanidas; Harvey D White; E Magnus Ohman; Steven V Manoukian; Martin Fahy; Roxana Mehran; Gregg W Stone Journal: Am Heart J Date: 2011-02 Impact factor: 4.749
Authors: Dominic Kelly; Iain B Squire; Sohail Q Khan; Paulene Quinn; Joachim Struck; Nils G Morgenthaler; Joan E Davies; Leong L Ng Journal: J Card Fail Date: 2008-08-30 Impact factor: 5.712
Authors: Tracy Y Wang; Fang-Shu Ou; Matthew T Roe; Robert A Harrington; E Magnus Ohman; W Brian Gibler; Eric D Peterson Journal: Circulation Date: 2009-04-27 Impact factor: 29.690
Authors: Hans L Hillege; Dorothea Nitsch; Marc A Pfeffer; Karl Swedberg; John J V McMurray; Salim Yusuf; Christopher B Granger; Eric L Michelson; Jan Ostergren; Jan Hein Cornel; Dick de Zeeuw; Stuart Pocock; Dirk J van Veldhuisen Journal: Circulation Date: 2006-02-07 Impact factor: 29.690
Authors: Kenneth W Mahaffey; Qinghong Yang; Karen S Pieper; Elliott M Antman; Harvey D White; Shaun G Goodman; Marc Cohen; Neal S Kleiman; Anatoly Langer; Philip E Aylward; Jacques J Col; Craig Reist; James J Ferguson; Robert M Califf Journal: J Gen Intern Med Date: 2008-01-15 Impact factor: 5.128
Authors: Jassim Al Suwaidi; Donal N Reddan; Kathryn Williams; Karen S Pieper; Robert A Harrington; Robert M Califf; Christopher B Granger; E Magnus Ohman; David R Holmes Journal: Circulation Date: 2002-08-20 Impact factor: 29.690
Authors: Sohail Q Khan; Onkar S Dhillon; Russell J O'Brien; Joachim Struck; Paulene A Quinn; Nils G Morgenthaler; Iain B Squire; Joan E Davies; Andreas Bergmann; Leong L Ng Journal: Circulation Date: 2007-04-09 Impact factor: 29.690